Come up with a name for your new list and we'll add to it:
Mediti Pharma raised a round of funding on June 20, 2016. Investors include
TVM Capital Life Science.
Mediti Pharma is developing a compound, MP-101, originally discovered by Eli Lilly and Company for the treatment of Alzheimer's disease (AD) psychosis. …